Recent News

• 03.13.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.03.2025 - TD Cowen’s 45th Annual Health Care Conference
• 02.27.2025 - Fourth quarter and Full-year 2024 Financial Results and Corporate Updates
• 02.27.2025 - Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
• 02.27.2025 - Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
• 02.21.2025 - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
• 02.21.2025 - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
• 02.18.2025 - Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
• 02.18.2025 - Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
• 02.12.2025 - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Recent Filings

• 02.27.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 8-K Current report
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2025 - 3 Initial statement of beneficial ownership of securities